MAXRELIEF (Natures Investment Holdings Pty Ltd)


Welcome to the PulseAid listing for the MAXRELIEF drug offered from Natures Investment Holdings Pty Ltd. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Natures Investment Holdings Pty Ltd
NON-PROPRIETARY NAME: ARNICA MONTANA FLOWER
SUBSTANCE NAME: ARNICA MONTANA FLOWER; ROSEMARY OIL; EUCALYPTUS OIL
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: TOPICAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2012-01-01
END MARKETING DATE: 0000-00-00


MAXRELIEF HUMAN OTC DRUG Details:

Item DescriptionMAXRELIEF from Natures Investment Holdings Pty Ltd
LABELER NAME: Natures Investment Holdings Pty Ltd
DEA SCHEDULE:
ACTIVE STRENGTH: 50; 110; 6(mg/120mL; mg/120mL; mg/120mL)
START MARKETING DATE: 2012-01-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 76509-001_85541720-1282-4fd8-ba80-6e93fc7a2741
PRODUCT NDC: 76509-001
APPLICATION NUMBER:

Other ARNICA MONTANA FLOWER; ROSEMARY OIL; EUCALYPTUS OIL Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Natures Investment Holdings Pty LtdMAXRELIEF